Temenos AG (LON:0QOA)
73.73
+0.32 (0.43%)
At close: Jul 31, 2025
Verve Therapeutics Market Cap
Temenos AG has a market cap or net worth of 4.59 billion as of August 1, 2025. Its market cap has increased by 12.38% in one year.
Market Cap
4.59B
Enterprise Value
5.02B
Revenue
790.85M
Ranking
n/a
PE Ratio
20.86
Stock Price
$73.73
Market Cap Chart
Since June 27, 2001, Temenos AG's market cap has increased from 324.42M to 4.59B, an increase of 1,315.65%. That is a compound annual growth rate of 11.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 4.59B | 11.44% |
Dec 30, 2024 | 4.12B | -21.52% |
Dec 29, 2023 | 5.25B | 60.66% |
Dec 30, 2022 | 3.27B | -55.32% |
Dec 30, 2021 | 7.32B | -1.82% |
Dec 30, 2020 | 7.45B | -12.81% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
The Sage Group | 11.41B |
Wise plc | 10.35B |
Spectris | 4.05B |
Softcat | 3.18B |
Computacenter | 2.41B |
Renishaw | 2.16B |
Alphawave IP Group | 1.35B |
Spirent Communications | 1.13B |